Olmesartan Medoxomil
Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Ascend Laboratories, LLC | generic | 16 | SUPPLYING |
| Inventia Healthcare Limited. | unknown | 11 | SUPPLYING |
| Modavar Pharmaceuticals LLC | unknown | 10 | SUPPLYING |
| Cadila Pharmaceuticals Limited | unknown | 10 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 10 | SUPPLYING |
| A-S Medication Solutions | repackager | 6 | SUPPLYING |
| Rising Pharma Holdings, Inc. | generic | 6 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 4 | SUPPLYING |
| Proficient Rx LP | repackager | 3 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Presence of Foreign Tablet/Capsule — Recalling firm: Ascend Laboratories LLC — Nationwide
cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement. — Recalling firm: Ascend Laboratories LLC — Nationwide in the U.S.
